Notably, the expression of CD56, a neural cell-adhesion molecule, in ALCL is associated with a poorer overall prognosis, increased recurrence, CNS involvement, and a higher likelihood of bone involvement [14,26]. This evidence concerns the gene NCAM1 and anaplastic large cell lymphoma.